O-antigens are cell surface polysaccharides of many Gramnegative pathogens that aid in escaping innate immune responses 1 . A widespread O-antigen biosynthesis mechanism involves the synthesis of the lipid-anchored polymer on the cytosolic face of the inner membrane, followed by transport to the periplasmic side where it is ligated to the lipid A core to complete a lipopolysaccharide molecule 2 . In this pathway, transport to the periplasm is mediated by an ATP-binding cassette (ABC) transporter, called Wzm-Wzt. Here we present the crystal structure of the Wzm-Wzt homologue from Aquifex aeolicus in an open conformation. The transporter forms a transmembrane channel that is sufficiently wide to accommodate a linear polysaccharide. Its nucleotide-binding domain and a periplasmic extension form 'gate helices' at the cytosolic and periplasmic membrane interfaces that probably serve as substrate entry and exit points. Site-directed mutagenesis of the gates impairs in vivo O-antigen secretion in the Escherichia coli prototype. Combined with a closed structure of the isolated nucleotide-binding domains, our structural and functional analyses suggest a processive O-antigen translocation mechanism, which stands in contrast to the classical alternating access mechanism of ABC transporters.
from a bacterial protein N-glycosylation system, provided the first example of an exporter translocating UND-PP-linked substrates 6 .
Some systems signal completion of O-antigen biosynthesis by modifying the growing (non-reducing) end of the polysaccharide chain with, for example, phosphate, methyl, or sugar moieties 7 . The corresponding ABC transporter recognizes the modified terminus via a carbohydrate-binding domain (CBD) fused to the C terminus of its nucleotide-binding domain (NBD) to accomplish transport [8] [9] [10] (Extended Data Fig. 1 ). In other systems, export of uncapped glycans, such as O-antigens and teichoic acids, occurs without the involvement of CBDs 7 .
ABC transporters usually cycle between inward-and outwardfacing conformations to facilitate substrate transport. However, this 'alternating access' model may not apply to transporters translocating high molecular mass polymers, such as polypeptides, O-antigens, and capsular polysaccharides.
To elucidate the O-antigen translocation mechanism, we determined the crystal structure of A. aeolicus (Aa)Wzm-Wzt, which is homologous to the prototypical E. coli Wzm-Wzt and Staphylococcus aureus wall teichoic acid transporters 11 (Extended Data Fig. 2) . In a nucleotidefree state, Wzm-Wzt forms a continuous channel across the membrane. The similarity of the transporter to the E. coli O9a transporter allowed testing of functional predictions in vivo with an established prototype. Combined with structures of the transporter's isolated NBDs in a closed conformation, our structural and functional analyses suggest substrate entry and exit pathways and a model for O-antigen membrane translocation.
We initially expressed and purified the full-length AaWzm-Wzt transporter, with Wzm and Wzt forming the transmembrane domain and NBD, respectively. For crystallization, the C-terminal CBD of Wzt was removed, generating a construct including residues Letter reSeArCH proteins are fully functional in vivo if the CBD is expressed in trans 8, 10 . The 3.85 Å-resolution Wzm-WztN structure includes residues 2-255 of Wzm and 2-235 of WztN (Extended Data Table 1 and Extended Data Fig. 3) .
In a nucleotide-free state, Wzm-WztN adopts a compact structure containing a Wzm dimer interacting with a WztN dimer in an open conformation (Fig. 1a ). The transmembrane domains closely interact over the entire length of their transmembrane regions and surround a central transmembrane channel, formed by transmembrane helices 1, 2, and 5, which is open to the intra-and extracellular milieu (see below).
Wzm does not contain any crossover helices that would interact with WztN of the neighbouring half-transporter, unlike previously described bacterial exporters 12 . At its N terminus, Wzm forms an amphipathic interface helix that runs parallel to the Wzm-WztN interface, followed by six transmembrane helices. The loop connecting transmembrane helices 2 and 3 (TM2 and TM3) couples Wzm with WztN (coupling helix) and the periplasmic connection between TM5 and TM6 forms two re-entrant helices, PG1 and PG2. Overall, the Wzm architecture resembles the type-II ABC exporter topology, which has so far been observed only in human lipid exporters 13, 14 (Fig. 1b and Extended Data Fig. 4a ). Notably, the Wzm-WztN architecture, and thus probably its translocation mechanism, differs markedly from PglK, which translocates UND-PP-linked oligosaccharides 6 (Extended Data Fig. 4b ).
The NBDs of the transporter are separated by about 8 Å between the Walker A and signature motifs, sufficient for nucleotide diffusion 12 (Figs 1a and 2b). A defining feature of WztN is an extension of the β -strand 1/2 loop (residues 13-32), which forms a short 'gate helix' (residues 18-26) that rests near the Wzm-Wzm protomer interface at the putative water-lipid boundary ( Fig. 2a ). The gate helix packs against a loop connecting TM4 and TM5 of Wzm of the same half-transporter. This loop contains a conserved F-X-R/K-D motif, of which Phe164 interacts with Arg20 of the gate helix and Asp167 sits directly at the Wzm-Wzm interface ( Fig. 2a ). Additional interactions occur with backbone residues of the loop connecting the N-terminal interface helix and TM1 in the opposing Wzm subunit.
Because the C terminus of the gate helix is rotated away from the transmembrane region, the helix creates a wedge-shaped path towards the Wzm dimer interface, probably forming a substrate-binding pocket ( Fig. 2a ). At its centre, the gate helix contains a conserved positively charged residue (Arg20), which could be implicated in binding the UND-PP ( Fig. 2a and Extended Data Fig. 2a ). Strikingly, a preceding Tyr residue (Tyr14) packs against and stabilizes the gate helix on its membrane-distal side ( Fig. 2a ). Primary sequence alignments of homolo gous transporters reveal that the gate helix and the Tyr residue are characteristic features of all known O-antigen and wall teichoic acid ABC transporters (Extended Data Fig. 2a ), which accept substrates synthesized as UND-PP-linked intermediates 11, 15 .
We also determined the structure of the isolated NBD of WztN in two different crystal forms at 2.05 and 3.5 Å resolution (Extended Data Table 1 ). Despite the absence of a stabilizing nucleotide, both structures represent a WztN dimer in a closed conformation, with only about 4.0 Å between the hydroxyl group of Ser61 (Walker A) and the backbone amide nitrogen of Ser143 (signature) ( Fig. 2c and Extended Data Fig. 5 ). This closed conformation is in agreement with the adenosine 5′-(β,γ-imido)triphosphate-stabilized closed state of the NBDs of the maltose transporter 16 , and probably reflects the nucleotide-bound conformation of Wzm-Wzt (Fig. 2b, c and Extended Data Fig. 5 ).
The transporter's transmembrane domain is formed by two closely interacting Wzm protomers that contact each other through TM1 and TM5 ( Fig. 3a ). TM5 is capped at the C terminus by a cluster of conserved aromatic residues that pack against the C-terminal end of TM1 of the opposing Wzm protomer. Strikingly, the Wzm protomers enclose a large channel spanning the entire membrane (Fig. 3b ). The channel is constricted near the periplasmic exit as well as the Wzm-WztN interface, yet continuously accessible to a 3.5 Å radius probe, thus capable of accommodating a polysaccharide. The structure of the native substrate of AaWzm-Wzt is currently unknown but a model of the E. coli O9a polymannose antigen can be accommodated, with eight to ten sugar units spanning the channel (Fig. 3c ).
The channel is lined with aromatic residues that are organized in three layers. First, Tyr18, Trp27 and Trp31 reside at the cytosolic Wzm-Wzm interface where the channel is widest. Second, Tyr39, Phe69, Trp71, Phe72, Phe180 and Trp181 form a central layer halfway across the membrane, and Phe43, Tyr60 and Phe195 surround the periplasmic channel exit ( Fig. 3b, d ). Protein-carbohydrate interactions are frequently mediated by CH-π stacking interactions between aromatic residues and the sugar rings 17 . Clustering of these residues within the channel strongly suggests a role in O-antigen coordination during transport. Indeed, a continuous and mostly conserved 'aromatic path' runs from the putative cytosolic substrate entrance to the periplasmic channel exit ( Fig. 3d and Extended Data Fig. 2 ). Similar paths have been described in cellulose synthase, cellobiohydrolase 1 and maltoporin [18] [19] [20] . As discussed for the maltoporin channel, hydrophobic interactions with aromatics are often combined with a continuous pattern of hydrogen-bond donors and acceptors that contact the hydroxyl groups of the polymers and probably minimize translocation energy barriers 20 . Tyr39, Ser75, Asn76, Ser79, Arg80, Glu110 and Gln177 may serve this purpose in Wzm-WztN ( Fig. 3d ).
At the periplasmic channel exit, the PG1 helix is also preceded by a conserved aromatic residue, usually a tyrosine (Tyr187), similar to the gate helix on the cytosolic side ( Fig. 3c ). It is thus likely that PG1 forms the gate towards the periplasmic membrane leaflet. The functional importance of the gate helices was addressed by introducing Letter reSeArCH point mutations into the E. coli Wzm-Wzt O9a transporter and monitoring O-antigen export in vivo 8, 9 . Tyr14 and 187 of AaWzm-Wzt correspond to Tyr15 and 192 in E. coli Wzm-Wzt, respectively (Extended Data Fig. 2 ). As shown in Fig. 3e and Extended Data Fig. 6 , replacing Tyr15 at the cytosolic gate of Wzt with Trp or Phe supports O-antigen export similar to wild-type levels, whereas replacing it with the hydrophobic β -branched residues Val and Ile abolishes export. Among the charged residues, Lys and Arg support some export, requiring longer incubation periods (post-induction) before reaching detectable levels, whereas the Y15E mutant is inactive. Replacing Tyr15 with Ala or Leu only shows a kinetic effect, the exported O-antigen levels reach wild-type levels about 30 min after initiating transport. This is possibly due to a second Tyr directly N-terminal to the conserved residue, which could functionally replace Tyr15 in E. coli Wzt. We were unable to express a Wzt double Tyr mutant to test this hypothesis. These results are consistent with the cytosolic gate forming the substrate-binding pocket, perhaps through CH-π stacking interactions of the tyrosine with the first sugar moiety of the substrate. On the periplasmic side, Tyr192
of Wzm is less critical for export, as most of the tested substitutions supported O-antigen secretion (Extended Data Fig. 6 ). It is likely that, once initiated, translocation is completed even with a compromised periplasmic gate and/or that other aromatic residues nearby functionally replace Tyr192. The CBD extending the NBD of the transporter (Extended Data Fig. 2c ) interacts with the modified terminus of the O-antigen substrate 8, 9 . Crystal structures of isolated CBDs from Raoultella terrigena and E. coli O9a reveal CBD dimers that are stabilized by intermolecular β -strand exchange 9,10 and, accordingly, the CBD of AaWzt also purifies as a dimer (Extended Data Fig. 7 ). Binding of the O-antigen cap probably occurs on the surface of the jelly-roll fold 9,10 ( Fig. 4a) , but the precise orientation of the CBD relative to the NBD remains unknown.
In the absence of the CBD, Wzm-WztN hydrolyses ATP in a detergent-solubilized state in a tested temperature range from 27 to 65 °C, with an apparent Michaelis constant (K m ) for ATP of about 350 μ M at 27 °C ( Fig. 4b and Extended Data Fig. 8 ). Strikingly, the full-length transporter hydrolyses ATP about seven times faster than the truncated One Wzm protomer is shown as a surface and the opposing subunit is shown as a cartoon. Both subunits are shown as cartoons in the close-up view. TM1 and TM5 are coloured red and green, respectively, and the interface helix is coloured beige. Conserved residues are shown as sticks. b, Surface representation of the Wzm-WztN channel. The channel volume accessible to a 3.5 Å-radius probe is shown as a green surface and aromatic residues lining the channel are shown as brown spheres. Selected residues are labelled. c, Cytosolic and periplasmic gate helices at the Wzm protomer interface. A model of the E. coli O9a antigen containing ten mannose units was manually placed in the channel and is shown as a red surface. d, Putative translocation path (red dotted line). Channel-exposed aromatic and polar residues are shown as brown sticks. e, In vivo O-antigen translocation. The indicated point mutations were introduced into E. coli O9a Wzm-Wzt. O-antigen export was detected after inducing transporter expression by silver staining (Ag) of whole-cell lysates, detecting exported and lipopolysaccharide-linked O-antigens only. Western blots detecting Wzt and maltose-binding protein (MBP) were performed to monitor transporter expression and as a loading control, respectively. All results have been confirmed at least three times as technical replicates. Time, period after inducing Wzt-Wzm expression.
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version, but a similar apparent K m for ATP suggests that the CBD accelerates the rate-liming step of ATP hydrolysis (Extended Data Fig. 8c ).
To investigate a direct interaction of Wzm-WztN with the CBD, we measured its hydrolytic activity in the presence of increasing CBD concentrations in detergent-solubilized and liposome-reconstituted states. The ATPase activity of Wzm-WztN increases with increasing CBD concentrations and reaches maximum rates at an approximately threefold molar excess of CBD over Wzm-WztN, consistent with a direct CBD-NBD interaction (Fig. 4b) . Control experiments in which purified CBD was added to the full-length transporter did not increase its hydrolytic activity. Instead, we observed a slight reduction in ATPase activity, perhaps because of non-specific interactions of the isolated and NBD-attached CBDs (Extended Data Fig. 8b ).
Compared with detergent-solubilized states, the hydrolytic activities of the transporters increase significantly upon reconstitution into liposomes (Extended Data Fig. 8c ). Assuming similar concentrations of catalytically active transporters, the apparent catalytic rates in liposomes increase about 3-and 20-fold for full-length and truncated Wzm-Wzt, respectively, relative to the detergent-solubilized states. These data suggest that the transporter adopts a different, perhaps closed, conformation in a lipid bilayer environment or the presence of the CBD, thereby affecting its hydrolytic activity. These properties could be modulated by the O-antigen to facilitate translocation.
In the absence of a translocating substrate in vivo, the transporter's transmembrane channel must be closed to prevent leakage of small solutes across the membrane. Channel closure probably correlates with closing of the transporter's NBDs, perhaps through rigid body movements of the Wzm-Wzt half transporters relative to one another. This state can be modelled by superimposing the NBDs of the Wzm-WztN transporter halves with the closed structure of the isolated WztN dimer (Fig. 2c ). In this model, the transmembrane channel is closed because the Wzm subunits pack tightly against each other without any significant backbone clashes (Extended Data Fig. 9 ). However, significant overlaps occur at the putative cytosolic substrate-binding site, where the gate helix of WztN contacts the interface helix-TM1 loop of the opposing Wzm subunit (Fig. 2 ). This region probably undergoes additional conformational changes during channel closure to facilitate substrate translocation (discussed below). The predicted rigid body movement of the transporter halves is supported by disulfide cross-linking of the Wzm subunits. Cys residues introduced into periplasmic loops predicted to be in close proximity in the closed conformation indeed form disulfide bridges under oxidizing conditions (Extended Data Fig. 9c ).
The channel-forming conformation of the ABC transporter is consistent with its biological function. However, in the absence of a polysaccharide, mechanisms must exist that prevent spontaneous transporter opening. It is possible that channel formation is tightly coupled to substrate recognition and insertion, such that the translocating polymer seals the channel ( Fig. 5 ).
It is unknown which end of the O-antigen enters the transporter first. Our structural and functional data argue that the gate helix of Wzt functions in substrate binding, most probably by recognizing the pyrophosphate group of UND-PP, together with the first sugar unit. Accordingly, some ABC transporters for O-antigens and teichoic acids that operate without the fine specificity imposed by CBDs can export glycans with different repeat-unit structures 21, 22 . Yet, all substrates contain an acetylated amino sugar as the connector between UND-PP and the repeat-unit glycan 7 . Our data suggest that Wzm-Wzt specifically recognizes this motif, in contrast to PglK, which has been proposed to recognize the undecaprenyl moiety 6 (Extended Data Fig. 4b ).
Substrate binding to the cytosolic entrance probably leads to opening of the transporter and insertion of the lipid head group into the channel through a gate between the Wzm subunits ( Fig. 5 ). Following insertion, the lipid anchor may spontaneously re-orient to the periplasmic side, possibly facilitated by the proton-motive force across the inner membrane. During this transition, the hydrophobic Letter reSeArCH part of the lipid anchor probably remains in the membrane, similar to the model proposed for PglK 6 . After this passive flipping, the transporter contains the polysaccharide in the channel proper. Export could be achieved in a single cycle or require several steps of ATP hydrolysis, however, these alternatives are currently impossible to distinguish. We speculate that the loop connecting the interface helix of Wzm with TM1 near the cytosolic gate (Figs 1 and 2) contacts the polysaccharide during NBD closure. The gate helix, upon ATP binding, probably pushes against this loop, such that it moves horizontally towards the channel (Fig. 2) . The loop contains several polar residues, including Thr21, which could interact with and move the polysaccharide during this transition, similar to the translocation mechanism proposed for cellulose synthase 23 . Conformational changes at the gate could mediate the translocation of about one or two sugar units at a time. As such, Wzm-Wzt would combine the functions of a lipid flippase and polysaccharide translocase.
ABC transporters exporting uncapped O-antigens (for example, K. pneumoniae O2a) do not contain C-terminal CBDs 22 . In these systems, polymer export is dependent on simultaneous synthesis, whereas in E. coli O9a, O-antigen synthesis and export can be temporally uncoupled 9, 22 . Both types of transporter share structural features key to our model (Extended Data Fig. 2 ). Whereas uncapped O-antigens may be synthesized and exported by multi-subunit complexes including the transporter, CBD-containing ABC transporters probably function independently during or after O-antigen biosynthesis. In this scenario, the CBD may ensure a sufficient local substrate concentration.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 

METHODS
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cloning and protein expression. The wzm and wzt genes were PCR amplified from genomic A. aeolicus VF5 DNA and sequentially cloned into an engineered pETDuet expression vector (Novagen) with a C-terminal histidine tag on Wzt. A second construct containing only residues 1-235 of Wzt (WztN) was cloned in a similar manner. The transporters were expressed in E. coli C43 cells in Luria broth (LB) medium upon induction with 0.5 mM isopropyl-β -d-thiogalactoside (IPTG) at an absorbance at 600 nm of 0.6. Cells were harvested by centrifugation after incubation at 37 °C for 4 h. The cells were resuspended in RB-1 buffer containing 20 mM Tris HCl pH 7.5, 0.1 M NaCl, and 5 mM β -mercaptoethanol (β -ME) and then lysed in a microfluidizer. The crude membranes were collected by centrifugation for 60 min at 200,000g in a Beckman Ti45 rotor and solubilized for 60 min at 4 °C in RB-2 buffer containing 50 mM sodium phosphate pH 7.2, 0.1 M NaCl, 20 mM imidazole, 5 mM β -ME, and 2% polyoxyethylene(8)-dodecyl ether (C12E8). The insoluble material was cleared by centrifugation for 30 min at 200,000g in a Beckman Ti45 rotor and the membrane extract was batch incubated with Ni-NTA agarose (Qiagen) for 60 min at 4 °C. The resin was packed in a gravity flow chromatography column, washed with 50 ml WB1 buffer (RB-1 buffer containing 20 mM imidazole and 5 mM dodecyl-N,N-dimethylamine-N-oxide (LDAO)), 50 ml WB2 buffer (RB-1 buffer containing 40 mM imidazole and 5 mM LDAO), and 50 ml WB3 buffer (RB-1 buffer containing a total of 1.5 M NaCl, 20 mM imidazole and 5 mM LDAO), and the transporter was eluted in 50 ml EB buffer containing 20 mM Tris HCl pH 7.5, 0.1 M NaCl, 300 mM imidazole, 5 mM β -ME, and 5 mM LDAO. The eluted protein was purified over an analytical S200 gel filtration column (GE Healthcare) equilibrated in buffer containing 20 mM Tris HCl pH 7.5, 0.1 M NaCl, 0.5 mM tris(2-carboxyethyl)phosphine (TCEP), and 5 mM LDAO. The peak fraction was concentrated to 15 mg ml −1 final concentration in a 50-kDa cut-off centrifugal filter (Amicon) before crystallization in the presence of 5 mM MgCl 2 . To guide model building, Thr128 in TM3 of Wzm was replaced with a Cys residue for derivatization with ethylmercurithiosalicylic acid. This mutant was generated by QuikChange mutagenesis and purified as described for the wild-type transporter. Selenomethionine-derivatized Wzm-WztN was prepared as described above with the exception that the cells were grown in the M9 minimal medium supplemented with 60 μ g ml −1 l-selenomethionine (Se-Met).
The CBD of Wzt (residues 235-394) was expressed from a pET30a vector (Novagen) in E. coli BL21 (DE3) cells (Invitrogen). The E. coli cells were cultured in LB medium at 37 °C and protein expression was induced at an optical density at 600 nm of 0.6 with 0.5 mM IPTG. The cells were harvested by centrifugation after 4 h of incubation at 37 °C. Subsequently, the cells were resuspended in RB-1 buffer containing 20 mM sodium phosphate pH 7.5, 0.05 M NaCl and 5 mM β -ME and then lysed in a microfluidizer. The insoluble material was cleared by centrifugation for 30 min at 200,000g in a Beckman Ti45 rotor. The supernatant was batch incubated with Ni-NTA agarose (Qiagen) for 60 min at 4 °C. The protein was then purified by Ni-NTA affinity chromatography at 4 °C, washed with 50 ml WB1 buffer containing 25 mM Tris HCl pH 8.5, 0.5 M NaCl, 30 mM imidazole, and 5 mM β -ME, 50 ml WB2 buffer (WB1 buffer containing a total of 50 mM imidazole and 50 mM NaCl) and eluted with EB buffer, consisting of 25 mM Tris HCl pH 8.5, 50 mM NaCl, 300 mM imidazole, and 5 mM β -ME. The protein was further purified by gel filtration chromatography (Superdex-200) in 25 mM Tris, pH 8.5, 50 mM NaCl, 5 mM β -ME. Initial crystals were observed after approximately three days and reached their final size within two weeks for all samples. The crystals were collected and directly cryo-cooled in liquid nitrogen. WztN crystals grown in PEG 8000 were cryoprotected in the presence of 25% glycerol in the crystallization solution. Wild-type and Wzm-T128C crystals were soaked with 5-20 mM ethylmercurithiosalicylic acid for 2-20 h before harvesting. Structure determination. Diffraction data were collected at the Argonne National Laboratory beam lines SER-and GM/CA-CAT as well as the AMX and FMX beam lines at the Brookhaven National Laboratories (NSLS-II). Data were integrated in XDS and reduced in Aimless, as part of the CCP4 program suite 24 . The isolated WztN structure was determined after single anomalous dispersion phasing with an ethylmercurithiosalicylic-acid-derivatized crystal containing a WztN monomer per asymmetric unit in Phenix.autosol with subsequent model building 25, 26 . The obtained model was of sufficient quality for molecular replacement using Phaser with the native data set 27 , after which the model was manually completed in Coot 28 and refined in Phenix.refine 25 using TLS parameters 29 . In this crystal form, the protomers of a WztN dimer are related by crystallographic two-fold symmetry. The obtained model was used for molecular replacement of the crystal form containing a WztN dimer per asymmetric unit and the obtained model was completed in Coot and refined as described above. In this structure, residues 12-33 of chain A were disordered and not included in the final model. The final monomeric and dimeric WztN models contained 99.2/0.4/0.4% and 98.4/1.6/0% in the preferred, allowed, and outlier regions of the Ramachandran plot.
The AaWzm-WztN structure was determined by single anomalous dispersion phasing with an ethylmercurithiosalicylic-acid-derivatized wild-type Wzm-WztN crystal. Phasing was performed in Phenix.autosol without automated model building and based on five mercury sites near Cys residues in the transporter's NBDs. The obtained experimental phases to approximately 9 Å resolution were improved by non-crystallographic symmetry (NCS) averaging and solvent flattening using the program DM with manually built averaging and solvent masks 30, 31 . The improved phases allowed manual docking of the WztN NBDs as well as three partial transmembrane helices. The obtained poly-alanine model was used to improve averaging and solvent masks for subsequent rounds of NCS averaging. Following placement of another two partial transmembrane helices, the initial model was of sufficient quality for molecular replacement with the native and highest-resolution data set. Subsequently, NCS and cross-crystal averaging in DMMulti 31 was used to improve and gradually extend the phases to 3.85 Å resolution using a solvent mask that covered the entire transporter and an averaging mask covering a Wzm-WztN half-transporter. The greatly improved density maps were used to place additional regions as poly-alanine traces, refine the averaging and solvent masks, and iterative rounds of NCS and cross-crystal averaging until the backbone of the entire transporter could be traced and bulky residues were discernible. We confirmed the annotation of transmembrane helices and the assigned registers on the basis of seleno-methionines at positions 147 and 156 in transmembrane helix 4 and 205 in PG2, as well as a mercury-derivatized Cys residue introduced at position 128 at the C-terminal end of transmembrane helix 3. The initial model was built as a poly-alanine model and refined in Phenix.refine with NCS constraints. To generate a model containing all amino-acid side chains, the high-resolution structure of the NBD was docked into the Wzm-WztN density and manually refined. The Wzm subunit was manually built starting with aromatic amino acids and methionines, and cycles of NCS refinement in Phenix.refine. Additionally, refinement in Refmac5 with jelly-body refinement greatly improved the model 32 . Towards the end of the refinement, NCS restraints were used instead of constraints. The final Wzm-WztN model contains residues 2-235 of Wzt plus a KLHH sequence corresponding to an engineered HindIII restriction site and C-terminal His-tag. Wzm contains residues 2-255 (of 256 in total) with a short gap between residues 51 and 55 in chain C and 49 and 55 in chain D. The final model contains 93.5, 6.3, and 0.2% of the residues in favoured, allowed, and disallowed regions of the Ramachandran plot, respectively. The coordinates and structure factors have been deposited in the Protein Data Bank. All figures were generated using Pymol 33 and channel dimensions were analysed using HOLLOW 34 . Primary sequence alignments were generated in CLUSTALW Omega and displayed in Jalview 35 . ATPase activity measurements. The ATPase activity was measured using an NADH-consuming coupled method as described 36 . In a first step, the transporter was incubated in reaction buffer containing 10 mM MgCl 2 and the indicated amounts of ATP at 27 °C (or otherwise indicated temperatures) for 10 min, after which the samples were snap frozen in liquid nitrogen until all data points had been collected. In a second step, the thawed samples were incubated with NADH buffer containing 50 mM HEPES pH7.5, 8 U pyruvate kinase, 8 U lactate dehydrogenase, 4 mM phosphoenolpyruvate, 1 mM MgCl 2 , and 0.05 mM NADH at 22 °C for 5 min in the dark. At 22 °C, AaWzm-Wzt does not exhibit any detectable ATPase activity. ADP formation was quantified by following the decrease in NADH fluorescence at 450 nm (excitation at 340 nm) using a FluoroMax 3 (Horiba) fluorimeter at 22 °C. For ATPase assays in proteoliposomes, purified Wzm-Wzt was reconstituted into 3 mg ml −1 E. coli total lipid extract at a protein concentration Letter reSeArCH of 0.3 mg ml −1 . Vesicles were formed upon detergent removal using SM-2 Bio-beads (Bio-rad). For CBD titration experiments, the CBD of Wzt was premixed with transporter for 3 h at 4 °C before adding ATP and MgCl 2 . Decrease in NADH fluorescence was converted to molar concentrations on the basis of measurements of known standards. All experiments were repeated at least three times and data were fitted to Michaelis-Menten kinetics to calculate K m and V max values using GraphPad Prism 6. Error bars are deviations from the means. Disulfide cross-linking of Wzm-WztN. For disulfide cross-linking experiments, Wzm and WztN were co-expressed from pETDuet and pACYC vectors, respectively, with an N-terminal Flag-tag on Wzm and C-terminal His-tag on WztN. Protein purification was as described above with the exception that the gel filtration buffer contained 1 mM DTT instead of TCEP. Disulfide cross-linking experiments confirming the modelled closed conformation of Wzm-WztN were performed with purified detergent-solubilized transporter. Oxidation was induced with copper-phenanthroline or sodium tetrathionate (STT). A copper-phenanthroline stock solution was prepared by combining 0.36 M 1,10-phenanthroline monohydrate (VWR) (in 50% ethanol) with 0.24 M copper sulfate (Sigma) at a 2:1 volume ratio. STT was dissolved in double-distilled H 2 O at 80 mM concentration, and N-ethylmaleimide to block free cysteines was prepared at 1 M concentration in dimethylsulfoxide. Wild-type or Cys-introduced Wzm-WztN at 0.09 mM concentration was incubated with 4 mM copper-phenanthroline or STT and incubated for 40 min at room temperature followed by addition of 25 mM N-ethylmaleimide and incubation at 4 °C for 30 min. Samples oxidized in the presence of ADP/Mg 2+ were pre-incubated with 2 mM ADP and 2 mM MgCl 2 for 20 min at room temperature. The oxidized protein was resolved by non-reducing SDS-PAGE and protein bands were visualized by western blotting against an N-terminal Flag-tag on Wzm. Size-exclusion multi-angle light scattering. Mass measurements of the CBD of Wzt were performed on a Dionex UltiMate3000 HPLC system with a UV detection module (ThermoFisher), connected to a miniDAWN TREOS static light-scattering detector (Wyatt Technology) and Optilab T-rEX differential refractometer (Wyatt Technology). A 100-μ l sample at 0.1 mM concentration was loaded onto a Superdex 200 HR 10/300 GL column (GE Healthcare) equilibrated in 25 mM Tris, pH 8.5, 50 mM NaCl, 5 mM β -ME at a flow rate of 0.4 ml min −1 . Data were recorded and processed using ASTRA software (Wyatt Technology). E. coli O9 antigen modelling. An E. coli O9a antigen containing ten mannose units was modelled using the GLYCAM carbohydrate builder and manually placed into the AaWzm-WztN transmembrane channel (http://glycam.org/tools/ moleculardynamics/oligosaccharide-builder/build-glycan?id= 1). In vivo O-antigen export assays. Growth conditions. Bacterial cultures (Supplementary Information) were grown with aeration in LB base (Invitrogen) at 37 °C. Broth was supplemented with 100 mg ml −1 ampicillin, 0.4% d-mannose, and/or 0.1% l-arabinose where appropriate. Unless otherwise stated, cells were grown in the presence of 0.4% d-glucose to repress mannose uptake. DNA methods. Oligonucleotide primers were custom designed and obtained from Sigma Aldrich (Supplementary Information). PfuUltra DNA polymerase (Agilent) was used for PCR reactions, according to the manufacturer's instructions, and PCR product was treated with DpnI (New England Biolabs). DNA sequencing was performed by the Genomics Facility at the University of Guelph Advanced Analysis Center. Complementation. E. coli CWG638 transformants containing plasmids with wild-type or variant wzt, along with wzm in the native chromosomal organization, were used to ensure equal protein expression levels. Cultures were grown overnight in the presence of 0.4% d-glucose. E. coli CWG638 cannot produce its own GDP-mannose, the substrate of glycosyltransferases responsible for O9a O-antigen assembly, owing to a deletion of manA 8 ; therefore, O-antigen production relies upon mannose uptake. Accumulation of UND-PP-O9a intermediates in the absence of export results in growth defects that are alleviated by second-site mutations that repress O-antigen synthesis. Growth in glucose represses uptake of any trace amounts of mannose in the medium and prevents harmful O9a synthesis. Overnight cultures were diluted 1/10 in fresh LB supplemented with 0.4% glucose and grown for 4 h to an absorbance at 600 nm of approximately 1.0. Cells were subjected to centrifugation at 5,000g for 10 min, resuspended in fresh LB containing 0.4% d-mannose to induce O-antigen biosynthesis, and grown for 15 min at 37 °C with aeration. After 15 min, 0.1% l-arabinose was added to induce protein expression. Aliquots of culture were taken immediately and after 5, 10, 20, 30, and 60 min and put immediately on ice to suppress further cell growth and O-antigen export. An equivalent of 1 optical density cells were harvested by centrifugation at 13,000g and resuspended in 100 μ l of SDS-PAGE loading buffer. Cells were lysed by boiling for 10 min. For western immunoblots, samples were subjected to SDS-PAGE using 12% acrylamide resolving gels in Trisglycine buffer 37, 38 . For lipopolysaccharide analysis, samples were first treated with 500 μ g ml −1 proteinase K for 1 h at 55 °C before SDS-PAGE. Lipopolysaccharide was visualized by silver staining 39 .
For immunoblot analyses, material resolved by SDS-PAGE was transferred to nitrocellulose membranes (Protran; PerkinElmer Life Sciences). Wzt was detected using anti-Wzt primary antisera, generated in rabbits, and cross-reactive material adsorbed against E. coli CWG708 whole-cell lysate 8 . Goat-anti-rabbit secondary antibody conjugated to alkaline phosphatase (Cedarlane Laboratories) was used to facilitate detection with nitroblue tetrazolium and 5-bromo-4-chloro-3indoyl phosphate (Roche Applied Science). MBP was detected using monoclonal anti-MBP mouse primary antibody (New England Biolabs) with secondary alkaline phosphatase-conjugated goat-anti-mouse antibody (Jackson ImmunoResearch Laboratories) for detection with 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium. Data availability. Atomic coordinates for the atomic models have been deposited in the Protein Data Bank under accession numbers 6AN7 for Wzm-WztN, and 6AMX and 6AN5 for WztN.
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Extended Data Figure 3 | Anomalous difference and experimental electron density maps. a, Heavy atom positions used for experimental phasing and model building. Five native cysteines in the NBDs as well as an engineered Cys at the C terminus of TM3 (T128C) were modified with ethylmercurithiosalicylic acid, shown as green and red meshes and contoured at 4.5σ and 3σ, respectively. Only the mercury sites shown in green were used for mercury-single anomalous dispersion phasing.
The transmembrane domain contains three native Met residues, which were identified upon substitution with seleno-methionine (cyan mesh, contoured at 3σ). Shown are sigma-A-weighted anomalous difference electron densities; AaWzm-WztN is shown as a grey ribbon. b, Unbiased experimental sigma-A-weighted electron density after NCS and cross-crystal averaging and phase extension to 3.85 Å, contoured at 1σ. Corresponding author(s): Jochen Zimmer
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Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were triplicates to ascertain correct values and statistical methods were only used to calculate standard deviations.
Data exclusions
Describe any data exclusions.
No experimental data was excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
All replicas of the data shown produced similar results.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were not randomized as this is not applicable to the kind of biochemical and structural data generated.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was applied to the data used in this study as this is not applicable to the kind of biochemical and structural data generated.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
